Modelling of the membrane receptor CXCR3 and its complexes with CXCL9, CXCL10 and CXCL11 chemokines: Putative target for new drug design

Molecular Immunology

Volumn 47, Issue 2-3, 2009, Pages 332-339

  Trotta, Tiziana ^a   Costantini, Susan ^a,b   Colonna, Giovanni ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CROM (Oncology Research Centre of Mercogliano) Fiorentino Lo Vuolo   (Italy)

Author keywords

Chemokine receptors; Chemokines; Drug design; Immune response; Inflammation

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; CYSTEINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; LIGAND;

ARTICLE; COMPLEX FORMATION; DRUG DESIGN; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE; MOLECULAR MODEL; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INTERACTION; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; CATTLE; CELL MEMBRANE; CHEMOKINE CXCL10; CHEMOKINE CXCL11; CHEMOKINE CXCL9; DRUG DESIGN; HUMANS; HYDROGEN BONDING; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, CXCR3; RHODOPSIN; SEQUENCE ALIGNMENT; SURFACE PROPERTIES; THERMODYNAMICS;

EID: 70450224667     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.09.013     Document Type: Article

References (50)

1. Ali S., and Lazennec G. Chemokines: novel targets for breast cancer metastasis. Cancer Metastasis Rev. 26 (2007) 401-420
2. Altschul S.F., Gish W., Miller W., Myers E., and Lipman D.J. Best local alignment search tool. J. Mol. Biol. 215 (1990) 403-410
3. Blom N., Gammeltoft S., and Brunak S. Sequence- and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294 (1999) 1351-1362
4. Booth V., Keizer D.W., Kamphuis M.B., Clark-Lewis I., and Sykes B.D. The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. Biochemistry 41 (2002) 10418-10425
5. Booth V., Clark-Lewis I., and Sykes B.D. NMR structure of CXCR3 binding chemokine CXCL11 (ITAC). Protein Sci. 13 (2004) 2022-2028
6. Clark-Lewis I., Kim K.S., Rajarathnam K., Gong J.H., Dewald B., Moser B., Baggiolini M., and Sykes B.D. Structure-activity relationships of chemokines. J. Leukoc. Biol. 57 (1995) 703-711
7. Clark-Lewis I., Mattioli I., Gong J.H., and Loetscher P. Structure-function relationship between the human chemokine receptor CXCR3 and its ligands. J. Biol. Chem. 278 (2003) 289-295
8. Cole K.E., Strick C.A., Paradis T.J., Ogborne K.T., Loetscher M., Gladue R.P., Lin W., Boyd J.G., Moser B., Wood D.E., Sahagan B.G., and Neote K. Interferon-inducible T cell α chemoattractant (I-TAC): a novel ELR-CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 187 (1998) 2009-2021
9. Colvin R.A., Campanella G.S.V., Sun J., and Luster A.D. Intracellular domain of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function. J. Biol. Chem. 279 (2004) 30219-30227
10. Comeau S.R., Gatchell D.W., Vajda S., and Camacho C.J. ClusPro: an automated docking and discrimination method for the prediction of protein complexes. Bioinformatics 20 (2004) 45-50
11. Costantini S., Rossi M., Colonna G., and Facchiano A.M. Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease. J. Mol. Graph. Model. 23 (2005) 419-431
12. Costantini S., Colonna G., and Facchiano A.M. Simulation of conformational changes occurring when a protein interacts with its receptor. Comput. Biol. Chem. 31 (2007) 196-206
13. Costantini S., Buonocore F., and Facchiano A.M. Molecular modelling of co-receptor CD8αα and its complex with MHC class I and T-cell receptor in sea bream (Sparus aurata). Fish Shellfish Immunol. 25 (2008) 782-790
14. Costantini S., Colonna G., and Facchiano A.M. ESBRI: a software for evaluating the salt bridges in proteins. Bioinformation 3 (2008) 137-139
15. Cuff J.A., and Barton G.J. Application of enhanced multiple sequence alignment profiles to improve protein secondary structure prediction. Proteins: Struct. Funct. Genet. Proteins 40 (2000) 502-511
16. Fernandez E.J., and Lolis E. Structure, function, and inhibition of chemokines. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 469-499
17. Gianfrani C., Siciliano R., Facchiano A.M., Camarca A., Mazzeo F.M., Costantini S., Savati V.M., Maurano F., Mazzarella G., Iaquinto G., Bergamo P., and Rossi M. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology 133 (2007) 780-789
18. Hirano S., Iwashita Y., Sasaki A., Kai S., Ohta M., and Kitano S. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes. J. Gastroenterol. Hepatol. 22 (2007) 690-696
19. Hubbard S.J., Campbell S.F., and Thornton J.M. Molecular recognition. Conformational analysis of limited proteolytic sites and serine proteinase protein inhibitors. J. Mol. Biol. 220 (1991) 507-530
20. Jones S., and Thornton J.M. Principles of protein-protein interactions derived from structural studies. PNAS 93 (1996) 13-20
21. Kabsch W., and Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22 (1983) 2577-2637
22. Laich A., Meyer M., Werner E.R., and Werner-Felmayer G. Structure and expression of the human small cytokine B subfamily member 11 (SCYB11/formerly SCYB9B, alias I-TAC) gene cloned from IFN-γ-treated human monocytes (THP-1). J. Interferon Cytokine Res. 19 (1999) 505-513
23. Laskowski R.A., MacArthur M.W., Moss D.S., and Thornton J.M. PROCHECK-a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26 (1993) 283-291
24. Liu S., Zhang C., Zhou H., and Zhou Y. A physical reference state unifies the structure-derived potential of mean force for protein folding and binding. Proteins 56 (2004) pp. 93e101
25. Loetscher M., Loetscher P., Brass N., Meese E., and Moser B. Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur. J. Immunol. 28 (1998) 3696-3705
26. Loetscher P., Pellegrino A., Gong J.H., Mattioli I., Loetscher M., Bardi G., Baggiolini M., and Clark-Lewis I. The ligands of CXC chemokine receptor 3, I-TAC, MIG, and IP-10, are natural antagonists for CCR3. J. Biol. Chem. 276 (2001) 2986-2991
27. Loetscher P., and Clark-Lewis I. Agonistic and antagonistic activities of chemokines. J. Leukoc. Biol. 69 (2001) 881-884
28. McDonald I.K., and Thornton J.M. Satisfying hydrogen bonding potential in proteins. J. Mol. Biol. 238 (1994) 777-793
29. Meyer M., Hensbergen P.J., van der Raaij-Helmer E.M., Brandacher G., Margreiter R., Heufler C., Koch F., Narumi S., Werner E.R., Colvin R., Luster A.D., Tensen C.P., and Werner-Felmayer G. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection. Eur. J. Immunol. 31 (2001) 2521-2527
30. Nishioka Y., Manabe K., Kishi J., Wang W., Inayama M., Azuma M., and Sone S. CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages. Clin. Exp. Immunol. 149 (2007) 317-326
31. O'Donovan N., Galvin M., and Morgan J.G. Physical mapping of the CXC chemokine locus on human chromosome 4. Cytogenet. Cell. Genet. 84 (1999) 39-42
32. Orengo C.A., Michie A.D., Jones S., Jones D.T., Swindells M.B., and Thornton J.M. CATH-a hierarchic classification of protein domain structures. Structure 5 (1997) 1093-1108
33. Paladino A., Costantini S., Colonna G., and Facchiano A.M. Molecular modelling of miraculin: structural analyses and functional hypotheses. BBRC 367 (2008) 26-32
34. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., and Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
35. Proudfoot A.E. Chemokine receptors: multifaceted therapeutic targets. Nat. Rev. Immunol. 2 (2002) 106-115
36. Robert L.R. Chemokine as attractive targets in liver carcinogenesis. Am. J. Gastroenterol. 100 (2005) 499-501
37. Rotondi M., Chiovato L., Romagnani S., Serio M., and Romagnani P. Role of chemokines in endocrine autoimmune disease. Endocr. Soc. 28 (2007) 492-520
38. Ruehlmann J.M., Xiang R., Niethammer A.G., Ba Y., Pertl U., Dolman C.S., Gillies S.D., and Reisfeld R.A. MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma. Cancer Res. 61 (2001) 8498-8503
39. Sali A., and Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234 (1993) 779-815
40. Sauty A., Colvin R.A., Wagner L., Rochat S., Spertini F., and Luster A.D. CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell α chemoattractant (CXCL11). J. Immunol. 167 (2001) 7084-7093
41. Schneidman-Duhovny D., Inbar Y., Polak V., Shatsky M., Halperin I., Benyamini H., Barzilai A., Dror O., Haspel N., Nussinov R., and Wolfson H.J. Taking geometry to its edge: fast unbound rigid (and hinge-bent) docking. Proteins 52 (2003) 107-112
42. Schneidman-Duhovny D., Inbar Y., Nussinov R., and Wolfson H.J. PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res. 33 (2005) W363-W367
43. Sippl M.J. Recognition of errors in three-dimensional structures of proteins. Proteins 17 (1993) 355-362
44. Tensen C.P., Flier J., Van Der Raaij-Helmer E.M., Sampat-Sardjoepersad S., Van Der Schors R.C., Leurs R., Scheper R.J., Boorsma D.M., and Willemze R. Human IP-9: a keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). J. Invest. Dermatol. 112 (1999) 716-722
45. Thompson J.D., Higgins D.G., and Gibson T. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22 (1994) 4673-4680
46. Zeremski M., Petrovic L.M., and Talal A.H. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J. Viral Hepat. 14 (2007) 675-687
47. Zeremski M., Petrovic L.M., Chiriboga L., Brown Q.B., Yee H.T., Kinklabwala M., Jacobson I.M., Dimova R., Markatou M., and Talal A.H. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology 48 (2008) 1440-1450
48. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127
49. Walser T.C., Rifat S., Ma X., Kundu N., Ward C., Goloubeva O., Johnson M.G., Medina J.C., Collins T.L., and Fulton A.M. Antagonism of CXCR3 Inhibits lung metastasis in a murine model of metastatic breast cancer. Cancer Res. 66 (2006) 7701-7707
50. Xanthou G., Williams T.J., and Pease J.E. Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation. Eur. J. Immunol. 33 (2003) 2927-2936